DK167341B1 - Komprimeret tablet eller kapsel indeholdende methylprednisolon - Google Patents

Komprimeret tablet eller kapsel indeholdende methylprednisolon Download PDF

Info

Publication number
DK167341B1
DK167341B1 DK624287A DK624287A DK167341B1 DK 167341 B1 DK167341 B1 DK 167341B1 DK 624287 A DK624287 A DK 624287A DK 624287 A DK624287 A DK 624287A DK 167341 B1 DK167341 B1 DK 167341B1
Authority
DK
Denmark
Prior art keywords
tablet
methylprednisolone
capsule
weight
tablets
Prior art date
Application number
DK624287A
Other languages
Danish (da)
English (en)
Other versions
DK624287A (da
DK624287D0 (da
Inventor
Coenraad F Lerk
Gerad Klaas Bolhuis
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK624287A publication Critical patent/DK624287A/da
Publication of DK624287D0 publication Critical patent/DK624287D0/da
Application granted granted Critical
Publication of DK167341B1 publication Critical patent/DK167341B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK624287A 1986-04-01 1987-11-27 Komprimeret tablet eller kapsel indeholdende methylprednisolon DK167341B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84662086A 1986-04-01 1986-04-01
US84662086 1986-04-01
PCT/US1987/000302 WO1987005804A1 (en) 1986-04-01 1987-02-17 Methylprednisolone/sodium carboxymethyl starch tablet composition
US8700302 1987-02-17

Publications (3)

Publication Number Publication Date
DK624287A DK624287A (da) 1987-11-27
DK624287D0 DK624287D0 (da) 1987-11-27
DK167341B1 true DK167341B1 (da) 1993-10-18

Family

ID=25298443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK624287A DK167341B1 (da) 1986-04-01 1987-11-27 Komprimeret tablet eller kapsel indeholdende methylprednisolon

Country Status (8)

Country Link
EP (1) EP0301006B1 (no)
JP (1) JPH01501934A (no)
KR (1) KR880701098A (no)
AU (1) AU7084587A (no)
DK (1) DK167341B1 (no)
HK (1) HK58497A (no)
NO (1) NO175884C (no)
WO (1) WO1987005804A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE4290300T1 (de) * 1991-01-30 1993-10-07 Wellcome Found Wasserdispergierbare Tabletten
DE69330392T2 (de) * 1992-04-03 2001-11-08 Nippon Kayaku K.K., Tokio/Tokyo Cytarabine Ocfosfate enthaltende harte Kapsel
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
DE19855203A1 (de) * 1998-11-30 2000-05-31 Kurt Heinz Bauer Coprozessiertes Polysaccharidprodukt
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
US9925139B2 (en) 2004-04-22 2018-03-27 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
EP1916995B2 (en) * 2005-07-29 2022-06-29 Stichting Groningen Centre for Drug Research Ph-controlled pulsatile delivery system, methods for preparation and use thereof
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP6037687B2 (ja) * 2011-07-08 2016-12-07 サノフィ株式会社 グリメピリドを含有する口腔内崩壊錠
BE1021446B1 (nl) * 2015-01-06 2015-11-24 Stasisport Pharma Nv Methylprednisolon tablet en werkwijze
CN106265568B (zh) * 2016-08-30 2018-08-10 林州中农颖泰生物肽有限公司 一种水溶性醋酸地塞米松片及其制备方法
CN109925288A (zh) * 2017-12-18 2019-06-25 江苏开元药业有限公司 一种糖皮质激素药物片剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
ATE13486T1 (de) * 1980-11-12 1985-06-15 Ciba Geigy Ag Schnellzerfallende arzneimittel-presslinge.
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
WO1987005804A1 (en) 1987-10-08
NO175884C (no) 1994-12-28
HK58497A (en) 1997-05-09
KR880701098A (ko) 1988-07-25
NO874989L (no) 1987-11-30
NO874989D0 (no) 1987-11-30
NO175884B (no) 1994-09-19
DK624287A (da) 1987-11-27
EP0301006B1 (en) 1992-05-06
JPH01501934A (ja) 1989-07-06
AU7084587A (en) 1987-10-20
DK624287D0 (da) 1987-11-27
EP0301006A1 (en) 1989-02-01

Similar Documents

Publication Publication Date Title
DK167341B1 (da) Komprimeret tablet eller kapsel indeholdende methylprednisolon
CN102813663B (zh) 包含四氢叶酸的药物组合物
EP0803250B1 (en) Controlled release of steroids from sugar coatings
KR102539030B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
KR960009182B1 (ko) 제약정제, 제약과립 및 그의 제조방법
EP0722720B1 (en) Novel sugar coating composition for application to compressed medicinal tablets
JP2939262B2 (ja) 製薬顆粒剤
RU2166936C2 (ru) Способ получения дозировочных единиц путем мокрой грануляции
WO2015154718A1 (zh) 泊沙康唑药物组合物及其制备方法、应用和药物制剂
NO325824B1 (no) Efavirenz-kapsler eller -tabletter som omfatter et desintegreringsmiddel og en fremgangsmate for fremstilling av disse.
CN1064810A (zh) 低剂量的干药物制剂
JPH10194969A (ja) 錠剤組成物
CN107812195B (zh) (6s)‐5‐甲基‐四氢叶酸钙盐的稳定药物组合物
EA036288B1 (ru) Фармацевтические лекарственные формы
WO2012006154A1 (en) Pharmaceutical compositions containing vanoxerine
AU2002361396B2 (en) Matrix film tablet for the controlled release of natural mixtures of conjugated oestrogens
KR20070085558A (ko) 저 용량의 에스트라디올을 함유하는 경구 고형 제형
CN105106149B (zh) 左炔诺孕酮片及其制法
JP6367042B2 (ja) ボリコナゾールを含む医薬組成物
CN115177595A (zh) 一种噁拉戈利钠片剂及其制备方法
CN110520110A (zh) 包含5-氯-n4-[2-(二甲基磷酰基)苯基]-n2-{2-甲氧基-4-[4-(4-甲基哌嗪-1-基)哌啶-1-基]苯基}嘧啶-2,4-二胺的药物制剂
JP2008527019A (ja) 固体経口避妊薬
US12133854B2 (en) Pharmaceutical compositions of mifepristone
US11878025B2 (en) Pharmaceutical compositions of mifepristone
WO2023217694A1 (en) Pharmaceutical composition of bempedoic acid

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired